Search by Drug Name or NDC

    NDC 43376-0322-30 Fintepla 2.2 mg/mL Details

    Fintepla 2.2 mg/mL

    Fintepla is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by UCB, Inc.. The primary component is FENFLURAMINE.

    Product Information

    NDC 43376-0322
    Product ID 43376-322_5dc79cac-29be-48b8-9dd1-0613731abc9d
    Associated GPIs 72600028102020
    GCN Sequence Number 081237
    GCN Sequence Number Description fenfluramine HCl SOLUTION 2.2 MG/ML ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 48284
    HICL Sequence Number 002116
    HICL Sequence Number Description FENFLURAMINE HCL
    Brand/Generic Brand
    Proprietary Name Fintepla
    Proprietary Name Suffix n/a
    Non-Proprietary Name fenfluramine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 2.2
    Active Ingredient Units mg/mL
    Substance Name FENFLURAMINE
    Labeler Name UCB, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212102
    Listing Certified Through 2024-12-31

    Package

    NDC 43376-0322-30 (43376032230)

    NDC Package Code 43376-322-30
    Billing NDC 43376032230
    Package 1 BOTTLE, PLASTIC in 1 CARTON (43376-322-30) / 30 mL in 1 BOTTLE, PLASTIC
    Marketing Start Date 2020-07-15
    NDC Exclude Flag N
    Pricing Information N/A